Cargando…
The New Era of Drug Therapy for Obesity: The Evidence and the Expectations
There is an urgent need for effective pharmacological therapies to help tackle the growing obesity epidemic and the healthcare crisis it poses. The past 3 years have seen approval of a number of novel anti-obesity drugs. The majority of these influence hypothalamic appetite pathways via dopaminergic...
Autores principales: | Jones, Ben J., Bloom, Stephen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464860/ https://www.ncbi.nlm.nih.gov/pubmed/25985865 http://dx.doi.org/10.1007/s40265-015-0410-1 |
Ejemplares similares
-
The Value and Deliverables of Medical Affairs: Affiliate Perspectives and Future Expectations
por: Farrington, Anupma Dhanda, et al.
Publicado: (2023) -
Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023) -
Auranofin: Repurposing an Old Drug for a Golden New Age
por: Roder, Christine, et al.
Publicado: (2015) -
Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy
por: Shorrock, Hannah K., et al.
Publicado: (2018) -
The Challenging Pharmacokinetics of Mitotane: An Old Drug in Need of New Packaging
por: Haider, Malik Salman, et al.
Publicado: (2021)